• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Botulinum Toxin A in the Treatment of Primary Axillary Hyperhidrosis: A Double-Dose Cohort Study.

Treatment of Primary Axillary Hyperhidrosis with Two Doses of Botulinum Toxin A-Observational Study.

机构信息

Physical Medicine and Rehabilitation Service, Río Hortega University Hospital, 47012 Valladolid, Spain.

出版信息

Toxins (Basel). 2024 Jul 16;16(7):320. doi: 10.3390/toxins16070320.

DOI:10.3390/toxins16070320
PMID:39057960
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11281711/
Abstract

Hyperhidrosis (HH) is defined as the production of more sweat than is necessary for its thermoregulatory function, negatively affecting patients' quality of life and interfering with their social, work and family life. In this context, the aim of thisstudy was to evaluate the efficacy of two different doses of botulinum toxin type A (50 or 100 units) in each axilla in severe primary axillary hyperhidrosis. A descriptive, observational, cross-sectional and post-authorisation study was conducted onpatients referred to our department.Thirty-one patients with severe primary axillary hyperhidrosis were included, some of whom received more than one infiltration during the follow-up period, performing a total of 82 procedures. They were assigned by simple random sampling to two types of treatment: infiltration of 50 or 100 units (U) of botulinum toxin A per axilla.Hyperhidrosis severity was assessed using the Hyperhidrosis Disease Severity Scale (HDSS), and quality of life was assessed using the Dermatology Life Quality Index (DLQI) questionnaire. Onabotulinum toxin A infiltration reduced the severity of hyperhidrosis and improved the quality of life of the treated patients, with no significant differences between the two groups.

摘要

多汗症(HH)被定义为产生的汗液超过其热调节功能所需的量,从而对患者的生活质量产生负面影响,并干扰他们的社交、工作和家庭生活。在这种情况下,本研究旨在评估两种不同剂量的肉毒杆菌毒素 A(50 或 100 单位)在每个腋窝中对严重原发性腋窝多汗症的疗效。对我们部门转介的患者进行了描述性、观察性、横断面和上市后研究。共纳入 31 例严重原发性腋窝多汗症患者,其中一些患者在随访期间接受了多次浸润治疗,共进行了 82 次治疗。他们通过简单随机抽样分为两种治疗类型:每侧腋窝注射 50 或 100 单位(U)肉毒杆菌毒素 A。多汗症严重程度使用多汗症疾病严重程度量表(HDSS)进行评估,生活质量使用皮肤病生活质量指数(DLQI)问卷进行评估。肉毒杆菌毒素 A 浸润降低了多汗症的严重程度,改善了治疗患者的生活质量,两组之间没有显著差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d42a/11281711/225cd6842d41/toxins-16-00320-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d42a/11281711/7fb0aaa8aba1/toxins-16-00320-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d42a/11281711/225cd6842d41/toxins-16-00320-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d42a/11281711/7fb0aaa8aba1/toxins-16-00320-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d42a/11281711/225cd6842d41/toxins-16-00320-g002.jpg